Immediate Impact
2 from Science/Nature 50 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Carla Motta being referenced
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine
2017
Endothelial PKCα-MAPK/ERK-phospholipase A2 pathway activation as a response of glioma in a triple culture model. A new role for pericytes?
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Carla Motta | 289 | 130 | 129 | 132 | 51 | 823 | |
| Noritaka Matsuo | 401 | 50 | 32 | 58 | 44 | 869 | |
| Tomoko Yamaguchi | 271 | 32 | 20 | 68 | 40 | 822 | |
| Mari Kogiso | 318 | 52 | 21 | 30 | 40 | 923 | |
| Anurag Tripathi | 171 | 47 | 46 | 54 | 40 | 800 | |
| Takuya Yashiro | 325 | 27 | 31 | 119 | 53 | 807 | |
| Xiaoyu Liu | 343 | 41 | 57 | 88 | 68 | 769 | |
| J. Sri Ram | 516 | 49 | 36 | 161 | 48 | 943 | |
| Chieh‐Shan Wu | 242 | 47 | 53 | 56 | 46 | 842 | |
| Makoto Takehana | 547 | 70 | 11 | 132 | 58 | 812 | |
| Edouard Delaive | 500 | 41 | 50 | 106 | 36 | 958 |
All Works
Login with ORCID to disown or claim papers
Loading papers...